A study just landed in Nature Communications that reframes how to think about midlife weight loss and brain health. Researchers followed 533 adults for up to 16 years after they completed lifestyle interventions, then scanned their brains and tested their cognition. The finding: it wasn't weight loss that predicted slower brain atrophy and better cognitive scores years later. It was sustained loss of visceral fat specifically.

‍

This matters because most people, and most doctors, still track weight on a scale. The number on the scale lumps together fat, muscle, water, and where on the body the fat actually sits. The new data suggests that for brain health, where the fat is matters more than how much of it there is.

‍

What the study found

‍

The research, called the Follow-Interventions-Trials (FIT) project, pulled participants from four earlier 18 to 24 month lifestyle randomized trials. The average age at follow-up was 61. Each participant had abdominal MRI, brain MRI, and Montreal Cognitive Assessment (MoCA) testing 5 to 16 years after their original intervention.

‍

Three findings stood out. Lower long-term visceral fat exposure, calculated across baseline, post-intervention, and follow-up, independently predicted higher cognitive scores. Visceral fat loss during the intervention period predicted higher brain volumes years later, independent of overall weight loss. And among the participants who had three full sets of scans over the years, lower long-term visceral fat was associated with a slower rate of brain atrophy.

‍

The same patterns were not observed for subcutaneous fat, the kind that sits under the skin and shows up on a pinch test. Visceral fat, the deeper fat surrounding the organs, was the variable that mattered.

‍

The proposed mechanism is glycemic. Visceral fat is metabolically active. It secretes inflammatory signals and contributes to insulin resistance. Both of these are increasingly understood as drivers of cognitive decline. When visceral fat goes down, glycemic control improves, and the brain appears to benefit downstream.

‍

Why this changes how we think about midlife weight

‍

Most people who decide to lose weight in their fifties do not distinguish between subcutaneous fat, visceral fat, and muscle. Many lose all three. Losing muscle in midlife is a problem on its own. Losing subcutaneous fat without losing visceral fat is largely cosmetic. Losing visceral fat appears to be the part that actually protects the brain.

‍

This also reframes "skinny fat." A person can have a body mass index in the normal range and still carry significant visceral fat. The scale will not flag this. A waist measurement, a DEXA scan, or abdominal imaging will.

‍

For anyone in their 40s, 50s, or 60s thinking about brain health, the practical question is no longer "should I lose weight." It is "what is my visceral fat doing, and what is actually moving it."

‍

What you can do

‍

Three things tend to move visceral fat without requiring dramatic restriction.

‍

The first is reducing refined carbohydrates and added sugars. Visceral fat is more responsive to insulin signaling than subcutaneous fat. Lowering postprandial glucose spikes is associated with reduced visceral fat over time.

‍

The second is consistent moderate-intensity movement, especially after meals. A 10 to 15 minute walk after eating blunts the post-meal glucose curve. Repeated over months, this contributes meaningfully to visceral fat reduction.

‍

The third is strength training, which we covered last week. Muscle is the primary site of glucose disposal in the body. More muscle means better glycemic control, which means less visceral fat accumulation.

‍

The biomarkers that respond, and the ones we look at first with members, are HbA1c (your average blood sugar over three months), fasting insulin, and the broader metabolic panel that looks at lipids and liver function. These shift before the scale shifts. They tell you whether the metabolic conditions that drive visceral fat are improving.

‍

The bottom line

‍

The next time someone tells you to lose weight for your brain, the more useful version of that advice is to lose visceral fat for your brain. The number on the scale was always a poor proxy for what is happening inside the body. The new research makes that clearer.

‍

If you are already a BetterBrain member, your most recent HbA1c, fasting insulin, and metabolic panel results are in your dashboard. Worth a fresh look in light of this.

‍

If you have not yet started, these markers are part of the BetterBrain Essentials Panel we look at first. 

‍

Strength Training and Brain Health: What 6 Months of Lifting Does to Your Hippocampus

Aerobic exercise gets most of the brain-health attention. The cardiovascular benefits are well-documented, the GPLD1 pathway connecting movement to blood-brain barrier repair is real, and almost every brain health protocol recommends it.

But a body of research has been quietly building on a different type of exercise entirely. And a comprehensive 2025 network meta-analysis just made the case for strength training impossible to ignore.

What the research found

The analysis, published in Frontiers in Aging Neuroscience, pulled data from dozens of randomized controlled trials involving cognitively healthy older adults. When researchers compared aerobic exercise, resistance training, mind-body practices like yoga, and combined programs for their effect on cognitive function, resistance training produced the strongest overall effect on global cognition. The effect size was considered moderate to large in cognitive research, where meaningful improvements are notoriously difficult to achieve.

A parallel 2025 systematic review went further. It examined actual brain imaging alongside cognitive testing. The findings: at least two resistance training sessions per week, sustained for at least six months, were associated with measurable increases in cortical thickness in two critical brain regions.

The hippocampus, your brain's primary memory formation center. And the prefrontal cortex, involved in planning, complex reasoning, and self-control. These are precisely the regions most vulnerable to aging and most associated with early cognitive decline.

These weren't just improvements in test scores. These were structural changes in brain tissue, visible on MRI scans. Six months of consistent strength training literally changed the physical structure of participants' brains.

How it works

The mechanisms connecting resistance training to brain health are distinct from aerobic exercise benefits, which is exactly why both matter.

When your skeletal muscles contract under load, they secrete signaling proteins called myokines into your bloodstream. One well-studied myokine, irisin, crosses the blood-brain barrier and has been shown to increase new brain cell formation and reduce neuroinflammation in research models.

Resistance training also improves insulin sensitivity in your muscles, contributing to better metabolic health throughout your body. Given that brain insulin resistance is increasingly understood as a central mechanism in Alzheimer's disease, this metabolic pathway from strength training to brain protection isn't minor.

The exact dose the research supports

Frequency: At least two sessions per week. Some studies suggest three sessions produce greater effects, following a dose-response pattern.

Duration: Six months minimum for structural brain changes to appear on imaging. This isn't a quick fix. It's a sustained practice.

Intensity: Moderate intensity works best, approximately 50 to 70 percent of your maximum. In practical terms, this means lifting a weight you can complete 8 to 12 controlled repetitions with, where the final 2 to 3 reps require genuine effort.

Going through the motions with very light resistance doesn't appear to produce the same stimulus. The dose matters as much as the activity itself.

You don't need a gym membership to start. Bodyweight exercises (squats, push-ups, lunges), resistance bands, or even filled water bottles work. The goal is progressive challenge over time, gradually increasing difficulty as you get stronger.

Tracking whether it's working

Several markers respond to consistent strength training and give you objective evidence the work is paying off.

Insulin sensitivity: Resistance training improves how your cells respond to insulin. You can track this through fasting insulin and HbA1c, which shows your average blood sugar control over three months. Better insulin sensitivity is associated with better cognitive function.

Inflammatory markers: Consistent strength training reduces systemic inflammation. hs-CRP and homocysteine levels respond, giving objective evidence of the anti-inflammatory effect.

Metabolic health markers: Strength training improves multiple metabolic markers including glucose control, lipid profiles like VLDL-C, and overall metabolic function. These improvements happen through muscle-mediated pathways that complement what aerobic exercise does.

Seeing these numbers move is concrete evidence that the effort is producing real change.

The case for combining aerobic and resistance training

Aerobic exercise works through the GPLD1 pathway, where your liver releases protective signals during movement that repair your blood-brain barrier.

Strength training works through entirely different pathways: muscle-derived signaling proteins, improved insulin sensitivity, and hormonal changes that protect brain structure.

These are complementary, not redundant. Research on combined programs shows that doing both produces greater cognitive benefit than either alone. If you're already doing aerobic exercise regularly, adding just two strength sessions per week hits the research-backed minimum.

If you're curious where your insulin sensitivity, inflammation, and metabolic markers stand, BetterBrain's Blueprint testing covers all of them in a single panel, plus 40 more brain health markers.

‍

Cholesterol gets a bad rap. For decades, we've heard that it clogs arteries and causes heart attacks. But here's what doesn't make headlines: your brain contains 25% of your body's total cholesterol despite making up only 2% of your body weight. As lipid expert Dr. Tom Dayspring puts it, "Cholesterol is almost certainly the most important molecule in the brain."

So how can cholesterol be both necessary for brain function and a major cardiovascular risk factor? The answer lies in understanding where cholesterol is, how it gets there, and what form it takes.

In this post, we're taking a deeper dive into cholesterol than usual. We'll break down what your cholesterol numbers actually mean, why the standard tests miss critical information, and how the cholesterol story connects cardiovascular health to brain health.

The Basics: What Is Cholesterol?

Cholesterol is a fatty molecule that serves critical functions throughout your body. It forms the outer layer of every cell, helps produce hormones (including testosterone, estrogen, and cortisol), enables vitamin D synthesis, and supports nerve function. Without cholesterol, you simply couldn't survive.

But there's an important distinction to make: "cholesterol" isn't one thing.

When we talk about cholesterol in the blood versus cholesterol in the brain, we're really talking about two separate systems that operate differently.

Blood cholesterol: Cholesterol travels through your bloodstream inside particles called lipoproteins. These particles come in different types:

• LDL (low-density lipoprotein): Often called "bad" cholesterol, LDL particles deliver cholesterol to cells throughout your body
• HDL (high-density lipoprotein): Called "good" cholesterol, HDL particles help transport excess cholesterol back to the liver
• VLDL (very low-density lipoprotein): Primarily transports triglycerides but also carries some cholesterol
• IDL (intermediate-density lipoprotein): A transition form between VLDL and LDL

Brain cholesterol: Your brain makes its own cholesterol and keeps it completely separate from blood cholesterol. The blood-brain barrier prevents cholesterol in your bloodstream from entering your brain. This means the cholesterol circulating in your blood and the cholesterol in your brain are part of two entirely different pools.

The Heart Risk: Why apoB Matters More Than LDL?

What is apoB?

ApoB (apolipoprotein B) is a protein found on the surface of all atherogenic (plaque-forming) particles, including LDL, VLDL, IDL, and Lp(a). Each particle contains exactly one apoB molecule, making apoB a direct count of total potentially harmful particles.

Why apoB beats LDL cholesterol?

Traditional LDL-C (LDL cholesterol) tells you how much cholesterol LDL carries, but not how many particles you have. Two people can have identical LDL-C but vastly different particle numbers and risk levels.

• Many small LDL particles (each carrying less cholesterol) = "normal" LDL-C but high particle count and high risk
• Fewer large LDL particles (each carrying more cholesterol) = higher LDL-C but fewer particles and potentially lower risk

ApoB counts every atherogenic particle regardless of size. This makes it the best single marker for cardiovascular risk.

What is the triglyceride connection?

Elevated triglycerides (often from insulin resistance) fundamentally alter lipid metabolism:

• VLDL becomes triglyceride-enriched
• Particles get remodeled into small, dense LDL
• ApoB particle count increases
• You can have "normal" LDL-C but dangerously high apoB

This is why metabolic health is critical for cardiovascular risk.

The Brain Side: Why Cholesterol Is Essential

While high apoB threatens your heart, brain cholesterol is absolutely essential.

Critical brain functions

• Myelin formation: Insulates nerve fibers for rapid signal transmission
• Synapse formation: Creates and maintains neuron connections
• Cell membranes: Every neuron needs cholesterol-rich membranes
• Neurotransmitter release: Regulates how neurons communicate

How the brain gets cholesterol

Astrocytes (brain cells) produce cholesterol and package it into brain-specific lipoproteins containing apoE (apolipoprotein E) for delivery to neurons.

The APOE genetic factor

• APOE ε2: Protective against Alzheimer's, better cholesterol handling
• APOE ε3: Most common, considered neutral
• APOE ε4: Increases Alzheimer's risk, disrupts brain cholesterol metabolism

Research from MIT shows APOE4 is associated with brain cells accumulating cholesterol abnormally rather than using it to make healthy myelin. This isn't about too much or too little cholesterol, but how effectively the brain uses it.

Cholesterol and Alzheimer's

Brain regions vulnerable to Alzheimer's show signatures of being "super cholesterol-hungry," as researchers describe it, constantly trying to produce and absorb cholesterol. When this system fails (especially with APOE4), neurodegeneration may follow.

The Paradox Resolved

In the bloodstream: High apoB drives atherosclerosis. Particles penetrate artery walls, oxidize, trigger inflammation, form plaques. Goal: Keep apoB low (<60-80 mg/dL) to prevent cardiovascular disease.

In the brain: The brain makes its own cholesterol independently. Blood cholesterol can't cross the blood-brain barrier. Goal: Support healthy brain cholesterol metabolism through metabolic health.

This separation means lowering blood cholesterol doesn't starve your brain. Your brain continues making what it needs regardless of apoB levels.

The Bottom Line

Cholesterol isn't inherently good or bad; context is everything. In your bloodstream, high apoB poses serious cardiovascular and cerebrovascular risks. In your brain, cholesterol is essential for structure and function.

The good news: these systems are separate. Lowering apoB to protect your heart doesn't harm your brain. In fact, protecting your cardiovascular system through better lipid management, metabolic health, and inflammation control also protects your brain.

Understanding which biomarkers matter empowers informed decisions. It's not about fearing cholesterol; it's about managing it intelligently.

Want to Understand Your Complete Lipid Profile and Genetic Risk?

BetterBrain includes apoB, advanced lipid testing, metabolic biomarkers, and APOE genetic testing for a complete cardiovascular and brain health picture.

‍

‍

As Alzheimer's disease continues to impact millions globally, the scientific community is increasingly focusing on the gut-brain axis. This complex communication network, which links the gastrointestinal tract and the brain, could play a major role in preventing cognitive decline. Recent discoveries¹ have shown that gut microbiota might affect everything from brain development to behavior to disease states, and researchers are starting to explore how the gut-brain axis can influence dementia risk.

‍

Exploratory study: A closer look at fiber's impact on aging brains

The School of Life Course & Population Sciences at King’s College London spearheaded a pivotal double-blind study² (the same type of study as used for clinical trials) with participants over 60 years old. Their research aimed to uncover the cognitive effects of consuming prebiotic fibers compared to a placebo.

‍

Fiber fuels cognitive fortitude

Like any organism, the components making up the gut microbiome need food to survive. One source of nutrients for them is prebiotic fibers, such as inulin and fructooligosaccharides (FOS), both of which were the focus of the King’s College study. The researchers found that participants who took prebiotic supplements had more of one species of healthy bacteria called Bifidobacterium in their gut. This species has previously been linked to better cognitive performance, and indeed the participants who took supplements showed improved cognitive function scores through the same memory tests that are used as an early indicator of Alzheimer’s disease.

‍

Why is this happening? 

The composition of the gut microbiome has drastically changed over human history. Advances in agriculture, industrialization and globalization may have caused a decrease in gut microbial diversity, which has been associated with worse health outcomes. In particular, a review of multiple studies¹ suggests that changes in the microbiome can lead to behavioral changes. In another study³ comparing 25 patients diagnosed with Alheimer’s disease to 25 healthy individuals, those with Alzheimer’s were found to have reduced gut microbial diversity. 

‍

Keeping an eye on your intake

Let’s get specific. Women should aim to consume 21-25g of fiber per day. Men should aim for 30-38g⁴. Here is a list of some common fiber-dense foods to consider adding into your diet.

‍

A promising path to cognitive health

Emerging evidence connecting dietary habits, gut microbiota, and brain function highlights a novel approach to combat Alzheimer’s disease. The gut-brain axis is still a new area of research - there is much we don’t know, and many researchers around the world are investigating the different ways in which the microbiome influences our brain health. Such studies not only pave the way for innovative therapeutic avenues but also emphasize the profound impact our diet can have on mental and overall health. 

‍

Putting the science in action

• Eat enough fiber each day to make sure you are nourishing your gut microbiome. Women should strive for 21-25g daily, while men should aim for 30-38g.
• Learn more about the importance of your gut health on your brain and body through the Peter Attia Drive podcast.some text
  • Episode #215 goes in-depth on the GI system - skip to 34:30 for ways in which the gut and brain communicate, and to 1:55:00 for ways to promote your gut microbiome using your nutrition.
  • Episode #283 discusses the microbiome specifically - learn more about the importance of fiber at 38:30 and about the gut-brain axis at 50:15. 

Homocysteine is a naturally occurring amino acid in our body and can spike acutely, such as after staying up all night. In healthy people, homocysteine naturally clears over time. However, at chronic high concentrations, it is associated with various health issues, including heart disease and, notably, cognitive decline. In fact, having blood homocysteine levels over 14 μmol/L is associated with a nearly doubled risk of dementia¹. Luckily, there are simple ways to lower your homocysteine levels - most notably B vitamin supplementation. 

‍

Brain Atrophy, Aging and Cognitive Decline

As we age, our brains naturally undergo some amount of atrophy, or decrease in size, which involves a loss of neurons and their connections. This process is accelerated in Alzheimer’s dementia². With a lower brain volume and fewer neural connections, it’s easy to see how atrophy can lead to lasting cognitive impairment. One factor that has a strong influence on the rate of brain atrophy is blood concentration of homocysteine. Several studies^3,4 link elevated homocysteine levels are linked with a heightened risk of dementia. 

‍

The role of B vitamins

You won’t often hear us say this, but you have an ace up your sleeve in fighting homocysteine: B vitamins. One study² investigated the effects of using B6, B9, and B12 vitamins over the course of two years, using the same level of rigor that is commonly used for drug clinical trials. 

On average, people who used B vitamins lowered their overall homocysteine levels by 32% and experienced a 30% slower rate of brain atrophy. In fact, those who started with very high levels of blood homocysteine (> 14 μmol/L) managed to slow their atrophy rate by 53%. In other words, this study suggests that the simple act of taking a daily B vitamin supplement can cut your dementia risk in half.

‍

The type of B vitamin matters

There are two factors to consider when selecting a B vitamin supplement. The first is what vitamins you are getting. The study mentioned above specifically tested the use of vitamins B6, B9 (also known as folate), and B12. It’s important to get a mix of both. The second is whether or not you select the methylated form of the vitamins. Methylation is a biological process that makes the vitamins more available for your body to use. In other words, the same dose of methyl-B vitamins will be more strongly absorbed than normal B vitamins. This is especially important for people with mutations in the MTHFR gene, since they otherwise have trouble absorbing B vitamins. We generally recommend taking methylated B vitamins since they are perfectly safe, but if you are sensitive to overmethylation, you may want to consider regular B vitamins to avoid side effects like headaches, anxiety, or irritability. 

‍

Broader Implications for Dementia Prevention

Homocysteine is a critically important risk factor for dementia. Not only does it accelerate brain atrophy, it also aggravates other conditions through inflammation and oxidative stress. Thankfully, B vitamins are an extremely effective tool to lower homocysteine levels. While there are many other ways of managing your homocysteine levels, most notably through diet, exercise, and stress management, B vitamins are a low-effort high-impact way to keep your brain atrophy at bay. 

‍

Get started on managing your homocysteine

• Measure your blood homocysteine levels to learn where you stand. Homocysteine is one of the 50+ biomarkers tested during your BetterBrain Essentials blood draw.
• Consider using B vitamin supplements to lower your homocysteine, ideally below 9 μmol/L. We recommend Pure Encapsulations MethylAssist, but make sure you use an unmethylated alternative if you are sensitive to overmethylation.
• Learn more about homocysteine on the Peter Attia Drive episode on dementia. This episode covers many topics, so if you’re just interested in homocystine, skip ahead to 1:09:00.

‍

When you think of air pollution, respiratory disease is usually the first thing to come to mind. However, recent findings from the Emory Healthy Brain Study¹ has begun to show that long-term exposure to tiny particles called PM2.5 has been associated with the accumulation of amyloid plaques in the brain, which is a hallmark of Alzheimer's disease. While this doesn't prove that PM2.5 exposure leads to Alzheimer's, it suggests a potentially elevated risk, especially among those exposed to poor quality air over longer periods of time.

Air quality is typically measured by the amount of specific pollutants in the air. The Emory Healthy Brain Study looked at a type of pollutant called PM2.5, which is fine particulate matter with a diameter of less than 2.5 micrometers (about 30 times smaller than a human hair). These particles are so fine they can bypass the body's airway defenses and enter the bloodstream. Common sources of PM2.5 include vehicle emissions, industrial combustion, and natural occurrences like wildfires. Because the particles can enter the bloodstream, they can cause health issues that go beyond simple respiratory irritation, potentially affecting brain health and contributing to cognitive decline.

‍

Key Findings from the Study

• Increased PM2.5 exposure is associated with worse results on Alzheimer’s pathology biomarkers: The study indicated that higher levels of PM2.5 exposure over one and three years are associated with lower concentrations of amyloid-beta 42 (Aβ42) in cerebrospinal fluid (CSF). Aβ42 is a biomarker whose decreased levels suggest an accumulation of amyloid plaques in the brain, which is a hallmark of Alzheimer’s dementia.
• Specific Focus on Traffic-Related PM2.5: While the study looked at both ambient (general environmental) and traffic-related PM2.5, the findings were particularly noteworthy for ambient PM2.5. This suggests that while traffic contributes significantly to PM2.5 levels, other sources of pollution also play a crucial role in influencing Alzheimer’s disease biomarkers.
• Implications for Alzheimer’s Risk: The research underscores that even PM2.5 below levels currently considered risky by environmental standards, there is a tangible increase in the risk of developing Alzheimer’s disease. This calls for a reassessment of what is considered “safe” exposure to PM2.5, particularly for populations at risk of Alzheimer’s.

‍

Reducing Exposure

Individuals living in high pollution areas can reduce their exposure by:

• Using air purifiers at home
• Avoiding outdoor activities when pollution levels are high
• Supporting clean air initiatives aimed at reducing emissions

‍

Conclusion

The findings from Emory University’s research are a vital addition to our understanding of environmental factors in Alzheimer’s disease risk. They not only highlight the need for stricter air pollution controls but also suggest that everyday actions to reduce exposure to PM2.5 could be a feasible strategy for Alzheimer's prevention. As we continue to uncover more about the impact of our environment on health, it becomes increasingly clear that tackling air pollution is not just about preserving our planet—it's also about protecting our minds.

‍